ResMed Asia Pte. Ltd.
USPTO PatentsView assignee record - 15 granted patents across 12 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Resmed ranks #19,081 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 12 technology areas.
- #19,081
- of 49,997 US assignees by volume
- Top 18%
- by Innovation Score (47.5/100)
- 9.4
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R19081 · Foreign Corporation #19,081 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 15 grants
- MID-PACK #19,081/49,997
- PHOTO-FINISH Rebound
- CPC-FOCUS A61M · 12 areas
- INNOV-PAR 47.5/100
- CLAIMS-PAR 9.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2023–2025 · 3y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Rebound Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Resmed’s 47.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Resmed
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- ResMed Asia Pte · this assignee
ResMed Asia Pte · this assignee
47 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Resmed's Innovation Score is 47.5/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Resmed?
Each dot is one of Resmed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Resmed’s own 9.4 claims/patent is at or below the 16.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Resmed's grants concentrate
ResMed Asia Pte. Ltd. is a focused PatentsView assignee: 12 CPC subclasses with 26.7% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2023 (5 grants) versus a trough of 4 in 2024. By volume, Resmed sits between Rebound Technologies, Inc. and RhinoSystems, Inc..
Resmed's three-year grant acceleration
ResMed Asia Pte. Ltd. shows 9 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at ResMed's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Rebound
Rebound Technologies, Inc.
15 patents
- Red Tail Hawk
Red Tail Hawk Corporation
15 patents
- Redx Pharma
Redx Pharma PLC
15 patents
- Rememdia LC
Rememdia LC
15 patents
- Research & Design…
Research & Design Innovations, LLC
15 patents
- Resodyn
Resodyn Corporation
15 patents
- Rhein Chemie Rhei…
Rhein Chemie Rheinau GmbH
15 patents
- Rhinosystems
RhinoSystems, Inc.
15 patents
- Resmed Asia Pte ◀
ResMed Asia Pte. Ltd.
15 patents
What this shows ResMed holds 15 patents at rank #19,091, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near ResMed
By rank, the assignees closest to #19,091 in granted patent volume.
- Rebound Technologies, Inc. #19,087 · 15 patents
- Red Tail Hawk Corporation #19,088 · 15 patents
- Redx Pharma PLC #19,089 · 15 patents
- Rememdia LC #19,090 · 15 patents
- Research & Design Innovations, LLC #19,092 · 15 patents
- Resodyn Corporation #19,093 · 15 patents
- Rhein Chemie Rheinau GmbH #19,094 · 15 patents
- RhinoSystems, Inc. #19,095 · 15 patents
Leaders in A61M (Devices FOR Introducing Media Into)
Other assignees with the most granted patents in ResMed's primary technology class.
- Becton, Dickinson and Company 1,249 in class
- Sanofi-Aventis Deutschland GMBH 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.V. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien LP 726 in class
- Terumo Kabushiki Kaisha 724 in class
- ResMed Pty Ltd 682 in class
Resmed's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
47 Top 18% higher than 82% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 5 | 33.3% |
| 2024 | 4 | 26.7% |
| 2025partial year | 6 | 40.0% |
Which technologies does ResMed Asia Pte. Ltd. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
ResMed Asia Pte. Ltd.'s patent record in context - here's where to go next.
- ResMed Asia Pte. Ltd.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 26.7% of its portfolio - see every assignee active in that class. Explore A61M
- Ranked #19,081 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare ResMed Asia Pte. Ltd. against Rebound Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 47.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.